InvestorsHub Logo
Followers 3
Posts 190
Boards Moderated 0
Alias Born 05/16/2013

Re: Whalatane post# 194660

Saturday, 06/01/2019 11:08:41 PM

Saturday, June 01, 2019 11:08:41 PM

Post# of 425940
What, you make point I have also been pondering. With Alzheimer studies ahead, not to mention EVAPORATE due later this year, why would AMRN feel it necessary to tackle EU approvals or even buyout at this point? I personally get the feeling they have been stalling on certain rollout options specifically to wait for results from EVAPORATE.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News